2doh: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The crystal structure of the human Pg-derived angiogenesis inhibitor, angiostatin, complexed to VEK-30, a peptide from the group A streptococcal, surface protein, PAM, was determined and refined to 2.3 A resolution. This, is the first structure of angiostatin bound to a ligand and provides a, model of the interaction between Pg and streptococcal-derived pathogenic, proteins. VEK-30 contains a "through-space isostere" for C-terminal, lysine, wherein Arg and Glu side chains, separated by one helical turn, bind within the bipolar angiostatin kringle 2 (K2) domain lysine-binding, site. VEK-30 also makes several contacts with K2 residues that exist, outside of the canonical LBS and are not conserved among the other Pg, kringles, thus providing a molecular basis for the selectivity of VEK-30, for K2. The structure also shows that Pg kringle domains undergo, significant structural rearrangement relative to one another and reveals, dimerization between two molecules of angiostatin and VEK-30 related by, crystallographic symmetry. This dimerization, which exists only in the, crystal structure, is consistent with the parallel coiled-coil full-length, PAM dimer expected from sequence similarities and homology modeling.
The crystal structure of the human Pg-derived angiogenesis inhibitor, angiostatin, complexed to VEK-30, a peptide from the group A streptococcal surface protein, PAM, was determined and refined to 2.3 A resolution. This is the first structure of angiostatin bound to a ligand and provides a model of the interaction between Pg and streptococcal-derived pathogenic proteins. VEK-30 contains a "through-space isostere" for C-terminal lysine, wherein Arg and Glu side chains, separated by one helical turn, bind within the bipolar angiostatin kringle 2 (K2) domain lysine-binding site. VEK-30 also makes several contacts with K2 residues that exist outside of the canonical LBS and are not conserved among the other Pg kringles, thus providing a molecular basis for the selectivity of VEK-30 for K2. The structure also shows that Pg kringle domains undergo significant structural rearrangement relative to one another and reveals dimerization between two molecules of angiostatin and VEK-30 related by crystallographic symmetry. This dimerization, which exists only in the crystal structure, is consistent with the parallel coiled-coil full-length PAM dimer expected from sequence similarities and homology modeling.


==Disease==
==Disease==
Line 17: Line 17:
[[Category: Plasmin]]
[[Category: Plasmin]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Castellino, F.J.]]
[[Category: Castellino, F J.]]
[[Category: Cnudde, S.E.]]
[[Category: Cnudde, S E.]]
[[Category: Geiger, J.H.]]
[[Category: Geiger, J H.]]
[[Category: Prorok, M.]]
[[Category: Prorok, M.]]
[[Category: DIO]]
[[Category: DIO]]
Line 26: Line 26:
[[Category: plasminogen]]
[[Category: plasminogen]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:22:04 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:00:58 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA